Adequate immune function must be maintained to protect the host from infection. While excessive inflammatory response may destroy normal tissues, antiinflammatory reaction and subsequent immunosuppression may also result in severe infection. It has recently been shown that the lower expression of human leukocyte antigen (HLA)-DR on monocytes correlates with the higher incidence of sepsis, and that interferon-gamma (IFN-γ) administration is effectively restores monocyte HLA-DR expression. We attempted IFN-γ treatment in a septic patient under monocyte HLA-DR expression monitoring. A 62-year-old man undergoing ventriculoperitoneal shunt surgery after subarachnoid hemorrhage suffered from shunt-tube infection and peritonitis. After undergoing celiotomy, he developed severe pneumonia refractory to antibiotic treatment to which the pathogen was sensitive in vitro. Low HLA-DR expression on monocytes, 47.2%, was determined and IFN-γ 1a therapy of 2.5×10
5JRU (Japanese reference unit)/day, div, for 7 days was begun. HLA-DR expression rose rapidly to 73.5% after 5 days and to 88.5% by 4 weeks. The patient recovered fully from pneumonia, and the PaO
2/FIO
2 ratio and APACHE II score improved in parallel with the restoration of monocyte HLA-DR expression. Monocyte HLA-DR expression measurement appears to be a reliable marker of immune function. IFN-γ treatment may thus become useful adjuvant therapy in immunologically compromised patients.
View full abstract